To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.

A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

One of the most exciting developments in cancer treatment is a wave of new cell therapies that train a patient's immune ...

Gut Microbes Release Cancer-Fighting Bile Acids That Block ... The scientists showed ... NK Cells Complexed With Bispecific Antibody Yield High Response Rates in Patients With Lymphoma Apr ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer ...

Senti Biosciences, Inc.’s SNTI share price has surged by 6.40%, which has investors questioning if this is right time to sell ...

A supplemental biologics license application has been submitted to the FDA for nogapendekin alfa plus Bacillus ...

LARKSPUR, CA, USA I April 14, 2025 I Aulos™ Bioscience, an immuno-oncology company working to revolutionize cancer care through development of ...